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Background: Exposure to solar ultraviolet-B (UV-B) radiation is a major source of vitamin D3. Chemistry climate
models project decreases in ground-level solar erythemal UV over the current century. It is unclear what impact this
will have on vitamin D status at the population level. The purpose of this study was to measure the association
between ground-level solar UV-B and serum concentrations of 25-hydroxyvitamin D (25(OH)D) using a secondary
analysis of the 2007 to 2009 Canadian Health Measures Survey (CHMS).
Methods: Blood samples collected from individuals aged 12 to 79 years sampled across Canada were analyzed for
25(OH)D (n = 4,398). Solar UV-B irradiance was calculated for the 15 CHMS collection sites using the Tropospheric
Ultraviolet and Visible Radiation Model. Multivariable linear regression was used to evaluate the association
between 25(OH)D and solar UV-B adjusted for other predictors and to explore effect modification.
Results: Cumulative solar UV-B irradiance averaged over 91 days (91-day UV-B) prior to blood draw correlated
significantly with 25(OH)D. Independent of other predictors, a 1 kJ/m2 increase in 91-day UV-B was associated with
a significant 0.5 nmol/L (95% CI 0.3-0.8) increase in mean 25(OH)D (P = 0.0001). The relationship was stronger
among younger individuals and those spending more time outdoors. Based on current projections of decreases in
ground-level solar UV-B, we predict less than a 1 nmol/L decrease in mean 25(OH)D for the population.
Conclusions: In Canada, cumulative exposure to ambient solar UV-B has a small but significant association with
25(OH)D concentrations. Public health messages to improve vitamin D status should target safe sun exposure with
sunscreen use, and also enhanced dietary and supplemental intake and maintenance of a healthy body weight.
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Climate models predict that in northern middle and high
latitudes the expected recovery of stratospheric ozone
from the effects of ozone-depleting substances over the
coming decades will be substantially augmented by an
increase in ozone from climate change [1]. Since strato-
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distribution, and reproduction in any medium(UV-B) received at the Earth’s surface, this increase in
stratospheric ozone implies a decrease in UV-B irradi-
ance. Projected decreases of erythemal UV using the
McKinlay-Diffey Erythema action spectrum, which is
directly proportional to UV Index, have been estimated
between 10 and 15% over the current century [2,3].
These atmospheric changes may affect human health
since solar UV-B exposure is a major source of vitamin
D3. Adequate vitamin D levels are necessary to maintain
physiologic calcium and phosphorous for normal bone
mineralization and to prevent rickets, osteomalacia and
osteoporosis [4]. Vitamin D has also been associatedtral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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cardiovascular disease, and autoimmune diseases [5].
Vitamin D in meaningful amounts is naturally available
in only a few foods, such as fatty fish, in addition to forti-
fied milk and supplements [5]. Vitamin D3 is synthesized
endogenously in human skin following exposure to UV-B
(280–315 nm) radiation in sunlight, which spontaneously
photoisomerizes 7-dehydrocholesterol to pre-vitamin D3
[6,7]. Pre-vitamin D3 is subsequently converted to vita-
min D3 by thermal isomerisation, which then enters the
circulation and is hydroxylated in the liver to long-lived
25-hydroxyvitamin D (25(OH)D3). 25(OH)D is the main
indicator of total vitamin D status and represents the
sum of vitamin D from both cutaneous synthesis and
dietary intake [8].
Since foods are naturally low in vitamin D, the preva-
lence of vitamin D insufficiency in some populations is
thought to result from inadequate exposure to sunlight
[8]. The solar zenith angle, which varies by latitude, sea-
son and time of day, determines the amount of absorp-
tion and scattering of solar UV-B radiation and thus the
intensity of sunlight at ground-level [9]. Stratospheric
ozone and other constituents with absorption features in
the UV-B region, clouds, aerosols, surface reflectivity
(albedo), and altitude, also affect the amount of solar
UV-B reaching the ground [9,10]. The association be-
tween solar UV-B and vitamin D is not straightforward,
since living in a sunny climate does not ensure sufficient
vitamin D status [11,12]. Vitamin D availability also
depends on personal and lifestyle factors including skin
pigmentation (increased melanin in darker skin naturally
blocks cutaneous synthesis of vitamin D3) [13], age (the
amount of 7-dehydrocholesterol in the skin decreases
with age) [14], dietary and supplemental intake [15], adi-
posity (storage of vitamin D in adipose tissue decreases
its bioavailability) [16], and sunlight exposure (when and
how long unprotected skin is exposed) [17].
In Canada, there is a high prevalence of low vitamin D
status, particularly in the winter [18-20]. Above 42°N
exposure to sunlight during the winter months is not
sufficient to initiate cutaneous production of vitamin D3
[21,22]. Approximately 26% of the Canadian population
has 25(OH)D concentrations that are inadequate for bone
health (< 50 nmol/L) [23]. Recent studies in Canada have
examined differences in vitamin D status by sex, age, eth-
nicity, body mass index (BMI), dietary intake, and vitamin
D supplementation [23-28]. However, these epidemiologic
studies used season, latitude, or time outdoors as proxy
measures for solar UV-B exposure. Thus it was not pos-
sible to determine the extent to which projected decreases
in solar UV-B radiation may impact on 25(OH)D concen-
trations at the population level. The primary objective of
this study was to quantify the association between
ground-level solar UV-B irradiance and serum 25(OH)Dconcentrations in the Canadian population and to exam-
ine factors that modify this relationship.
Methods
Study population
The 2007 to 2009 CHMS collected physical measure-
ments and blood and urine samples during visits to a
mobile clinic at 15 sites across Canada. Demographic
and lifestyle information were also gathered through
household interviews. Measurements at each site were
completed within a period of 36 to 57 days. The target
population was household residents aged 6 to 79 years,
excluding residents of Indian reserves, Crown lands, cer-
tain remote regions, institutions, and full-time members
of the Canadian Forces [29]. Approximately 96% of the
Canadian population was represented and the overall re-
sponse rate for participants who completed the mobile
clinic visit was 52% at the national level [30]. Blood sam-
ples were not collected from respondents with haemo-
philia or recent chemotherapy treatment (n = 8) and 289
respondents did not provide enough blood for the 25
(OH)D assay. Participants less than 12 years of age
(n = 908) were excluded from the analysis because life-
style factors and likely determinants of 25(OH)D differed
from adults who are the focus of the current study.
The study sample consisted of 4,398 respondents to
the CHMS, representing 26.4 million Canadians aged 12
to 79 years. Informed written consent was obtained from
respondents aged 14 years and older [31]. For younger
children, a parent or legal guardian provided written
consent, and written assent was obtained from the child.
Participation was voluntary and respondents could with-
draw from any part of the survey at any time. Ethics ap-
proval to conduct the survey was obtained from Health
Canada’s Research Ethics Board [31]. Data-sharing agree-
ments between Statistics Canada and the Public Health
Agency of Canada permitted the use of information col-
lected in the CHMS for statistical and research purposes.
Additional information about the CHMS methodology is
available in published papers and reports by Statistics
Canada [32,33].
Solar UV-B irradiance
Data on ground-level solar UV-B were calculated using
the Tropospheric Ultraviolet and Visible (TUV) Radiation
Model (version 4.6) [34]. The TUV radiative transfer
model used observations of atmospheric total ozone (O3)
and total nitrogen dioxide (NO2) from the satellite-based
Ozone Monitoring Instrument (OMI) and observations of
surface albedo from the European Centre for Medium-
Range Weather Forecasts (ECMWF) [35]. The shortwave
broadband albedo was used due to the difficulty of imple-
menting wavelength-specific values in the TUV model.
The model was modified to include observations of
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ground aerosols, air density, surface elevation, and solar
zenith angle to compute direct and diffuse downwelling
components of solar UV-B irradiance at the Earth’s surface
every 5 minutes between 11 am and 4 pm at the 15
CHMS sites. UV-B irradiance was integrated over the
wavelengths 280 to 315 nm. Three measures of ground-
level solar UV-B were examined as predictors of 25(OH)
D: (1) daily mean (11 am to 4 pm), (2) daily peak (at local
noon) and (3) n-day daily cumulative (11 am to 4 pm)
averaged over the 2 to 186 days prior to blood draw.
Serum 25(OH)D
Serum concentrations of 25(OH)D were analyzed using
the LIAISON 25-Hydroxyvitamin D TOTAL assay (Dia-
sorin, Ltd.) in three reference laboratories following
standard operating procedures and uniform assay proto-
cols [30]. The lower and upper limits of detection for
the chemiluminescent immunoassay are 10 nmol/L and
375 nmol/L, respectively. Analyses were performed sin-
gly with an intra and inter-assay variability from 3.2 to
8.5% and 6.9 to 12.7%, respectively. Serum 25(OH)D
concentrations less than the lower limit of detection
(9.98 nmol/L) were assigned a value half of the lower
limit (4.99 nmol/L) [36].
Other predictors
Sex, age, ethnicity (proxy for skin pigmentation), sun ex-
posure, sunscreen use, vitamin D supplementation, milk
consumption, salt water fish consumption, BMI, physical
activity index (PAI), cigarette smoking and alcohol use
were examined as other predictors of 25(OH)D. PAI was
derived in the CHMS from the sum of respondents’
average daily energy expenditures during all leisure time
activities in the past three months, and classified as in-
active (<1.5 kcal/kg/day), moderately active (1.5 to
2.9 kcal/kg/day), or active (≥ 3.0 kcal/kg/day) [30]. In-
formation about these predictors was collected in the
CHMS in-home interview questionnaire, clinic question-
naire or mobile clinic visit [30].
Statistical analyses
A square root transformation was applied to normalize
the 25(OH)D distribution. Simple linear regression was
performed for each predictor of 25(OH)D. Individual
measures of solar UV-B irradiance were bimodally dis-
tributed due to the timing and location of data collec-
tion, with each CHMS site sampled within a three
month period. Measures of solar UV-B irradiance were
modelled both as categorical and continuous variables
and a second-order term was added to the model to
allow a curvilinear relationship with 25(OH)D. There
was no evidence of non-linearity and results were similar
for categorical and continuous measures of solar UV-Birradiance. Data are presented for the continuous measure
only. The other predictors were examined as categorical
variables to explore interactions with solar UV-B irradi-
ance and to perform subgroup analyses. Levels of the vari-
ables measured in the CHMS were collapsed to minimize
the degrees of freedom while ensuring an adequate num-
ber of observations within each subgroup.
A multivariable model was built by backwards stepwise
selection from the full model and included all significant
predictors. Sunscreen use, season and latitude were not
adjusted for in the multivariable model because informa-
tion about sunscreen use was collected only for participants
who reported at least 30 minutes of sun exposure on a typ-
ical weekend or day off in the summer, and season and lati-
tude are collinearly related to solar UV-B irradiance. Effect
modification of the relationship between solar UV-B irradi-
ance and 25(OH)D was examined by simultaneously testing
interaction terms in the full model. Subgroup analyses were
performed within levels of the significant effect modifiers.
Point estimates were calculated using the survey weights to
be representative of the Canadian population covered and
to adjust for non-response. Variance estimates were calcu-
lated using the bootstrap method to account for the com-
plex sampling design of the CHMS. Confidence intervals
(CIs) and P-values were calculated using 11 degrees of free-
dom to reflect the 15 collection sites (clusters) and five
regions (strata) [30]. Significance was defined as P<0.05 for
main effects and P<0.01 for interaction effects. The multi-
variable model included data for 4,354 study participants
who had non-missing observations for all independent
predictors. Statistical analyses were performed using SAS
(version 9.2).
Results
Descriptive statistics for the study participants are pre-
sented in Table 1. The mean concentration of 25(OH)D
weighted for the Canadian population aged 12 to 79 years
was 67.2 nmol/L (95% CI 64.9-69.6) and ranged from 5.0
to 274.6 nmol/L. In simple linear regression, measures
of solar UV-B irradiance were positively correlated with
square root transformed 25(OH)D, although the rela-
tionship was non-significant for daily mean and daily
peak solar UV-B (data not shown). The correlation be-
tween n-day daily cumulative solar UV-B and 25(OH)D
was greatest for the 91-days prior to blood draw (91-day
UV-B) (r2 = 0.03) (Table 2). The mean 91-day UV-B
weighted for the Canadian population was 12.7 kJ/m2
(95% CI 9.9-15.5) and ranged from 1.4 to 24.8 kJ/m2.
The seasonal variation in UV-B exposure as shown by
the average daily UV-B (and range) calculated from the
model output for the 15 CHMS sites over the two years
of data collection was 4.4 kJ/m2 (1.0 to 15.7 kJ/m2) in
the winter (January to March); 19.5 kJ/m2 (9.3 to
27.3 kJ/m2) in the spring (April to June); 19.5 kJ/m2
Table 1 Characteristics of the sample and household
population aged 12 to 79 years, Canada, 2007 to 2009
Variable Sample
(Unweighted)
Population
(Weighted)
n % (95% CI)
Sex
Female 2289 50.0 (49.2, 50.7)
Male 2109 50.0 (49.6, 50.5)
Age
12-19 years 950 12.0 (11.6, 12.4)
20-59 years 2375 69.7 (69.1, 70.4)
60-79 years 1073 18.3 (18.0, 18.5)
Ethnicity
White 3696 81.7 (74.4, 88.8)
Non-White 696 18.3 (11.0, 25.5)
Sun Exposure
< 30 min/d 833 19.2 (16.1, 22.2)
≥ 30 min/d and<2 h/d 1210 27.5 (24.5, 30.4)
≥ 2 h/d 2350 53.4 (48.6, 58.0)
Sunscreen Use*
Never or rarely 1754 49.3 (45.4, 53.0)
Sometimes 672 18.9 (16.9, 21.0)
Often or always 1134 31.9 (28.7, 35.0)
Vitamin D Supplementation
No 3826 85.1 (78.8, 88.5)
Yes 572 14.9 (12.4, 20.4)
Milk Consumption
< Once/d 1790 42.9 (40.7, 45.2)
Once/d 1425 33.7 (32.5, 34.9)
> Once/d 1183 23.4 (21.1, 25.8)
Salt Water Fish Consumption
< Once/week 2178 49.7 (45.9, 53.5)
Once/week 1164 25.8 (24.0, 27.6)
> Once/week 1056 24.5 (21.5, 27.5)
Body Mass Index
< 25 kg/m2 1930 42.3 (37.7, 46.6)
≥ 25 and < 30 kg/m2 1453 34.7 (31.5, 37.2)
≥ 30 kg/m2 983 23.0 (19.6, 25.9)
Physical Activity Index
Inactive 2120 51.8 (46.3, 57.4)
Moderately Active 1107 24.5 (21.8, 27.1)
Active 1170 23.7 (20.1, 27.3)
Cigarette Smoking
Non-Smoker 3605 80.0 (77.0, 82.2)
Current Smoker 792 20.0 (18.1, 22.7)
Table 1 Characteristics of the sample and household
population aged 12 to 79 years, Canada, 2007 to 2009
(Continued)
Alcohol Use
Non-Drinker 1007 18.0 (16.4, 20.3)
Current Drinker 3390 82.0 (79.9, 83.4)
Season
January to March 896 21.8F (0.0, 43.6)
April to June 1269 31.4F (4.7, 58.1)
July to September 1063 20.5F (5.8, 35.2)
October to December 1170 26.3F (8.0, 44.6)
Latitude
43-44 oN 1615 38.8 (37.8, 39.8)
45-47 oN 1548 30.9 (30.7, 31.1)
49-54 oN 1235 30.3 (29.8, 30.8)
*Sunscreen use was collected only for participants who reported≥ 30 min/d
sun exposure.
FInterpret with caution (coefficient of variation 16.6-33.3%).
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and 5.4 kJ/m2 (1.6 to 14.8 kJ/m2) in the fall (October
to December). In univariate analysis, higher mean
25(OH)D was associated with female sex, older age
(60–79 years), white ethnicity, longer duration of sun
exposure (≥ 30 min/d), more frequent sunscreen use
(sometimes, often or always), vitamin D supplementa-
tion, increased milk consumption (≥ once/day), lower
BMI (< 30 kg/m2), increased PAI (active or moderately
active), current alcohol use, blood draw in the summer
(July to September) compared to the winter (December
to February), and medium latitude (45–47°N) compared
to high latitude (49–54°N) (Table 2).
Significant main effects in the multivariable model
were 91-day UV-B, sex, age, ethnicity, sun exposure,
vitamin D supplementation, milk consumption, BMI and
PAI (P<0.05) (Table 3). The multivariable model
explained 21% of the total variability in 25(OH)D. Ethni-
city was the strongest predictor of 25(OH)D and
accounted for 6% of the total variability, followed by 91-
day UV-B (3%), BMI (2%) and milk consumption (2%).
Vitamin D supplementation, sex, age, sun exposure, and
PAI each accounted for approximately 1% of the total
variability in 25(OH)D. Adjusted for personal and life-
style factors, a 1 kJ/m2 increase in 91-day UV-B was
associated with a significant 0.5 nmol/L (95% CI 0.3-0.8)
increase in mean 25(OH)D (P = 0.0001). Interactions be-
tween 91-day UV-B and age (P<0.0001) and PAI
(P = 0.002) were significant. The magnitude of the asso-
ciation between 91-day UV-B and 25(OH)D was ap-
proximately two times greater within the age group 12
to 19 years (β= 0.07) and within the physically active
group (β= 0.06), compared to the other subgroups
Table 2 Simple linear regression for square root transformed 25(OH)D weighted for the household population aged
12 to 79 years, Canada, 2007 to 2009
Variable β* ± SE 25(OH)D** P Model
(95% CI) r2
91-Day UV-B (kJ /m2) 0.04 ± 0.01 0.6 (0.2, 0.9) 0.0002 0.03
Sex 0.01
Female (Reference) 67.1 (65.0, 69.1)
Male −0.30 ± 0.07 62.3 (60.1, 64.4) < 0.0001
Age 0.01
12-19 years 0.14 ± 0.10 65.4 (62.3, 68.5) 0.16
20-59 years (Reference) 63.2 (60.6, 65.9)
60-79 years 0.41 ± 0.10 69.8 (66.7, 73.1) < 0.0001
Ethnicity 0.09
White (Reference) 68.4 (64.3, 72.8)
Non-White −1.27 ± 0.13 49.0 (46.0, 52.1) < 0.0001
Sun Exposure 0.01
< 30 min/d (Reference) 58.9 (55.9, 61.9)
≥ 30 min/d and< 2 h/d 0.34 ± 0.10* 64.2 (61.2, 67.2) 0.0003
≥ 2 h/d 0.52 ± 0.09 67.0 (64.4, 69.7) < 0.0001
Sunscreen Use 0.01
Never or rarely (Reference) 64.1 (61.6, 66.6)
Sometimes 0.11 ± 0.07 65.9 (63.8, 68.1) 0.09
Often or always 0.32 ± 0.07 69.3 (67.0, 71.6) < 0.0001
Vitamin D Supplementation 0.01
No (Reference) 63.6 (61.1, 66.1)
Yes 0.41 ± 0.13 70.2 (66.0, 74.6) 0.002
Milk Consumption 0.03
< Once/d (Reference) 60.0 (57.8, 62.2)
Once/d 0.36 ± 0.06** 65.7 (63.9, 67.6) < 0.0001
> Once/d 0.75 ± 0.06 72.1 (70.1, 74.1) < 0.0001
Salt Water Fish Consumption < 0.01
< Once/week (Reference) 63.8 (60.9, 66.8)
Once/week 0.04 ± 0.08 64.5 (62.0, 67.0) 0.60
> Once/week 0.17 ± 0.16 66.6 (61.7, 71.7) 0.27
Body Mass Index 0.02
< 25 kg/m2 (Reference) 67.2 (64.1, 70.5)
≥ 25 and < 30 kg/m2 −0.07 ± 0.08# 66.1 (63.7, 68.6) 0.38
≥ 30 kg/m2 −0.57 ± 0.09 58.2 (55.6, 60.8) < 0.0001
Physical Activity Index 0.02
Inactive (Reference) 60.8 (58.3, 63.4)
Moderately Active 0.46 ± 0.07 68.2 (65.9, 70.6) < 0.0001
Active 0.54 ± 0.11 69.6 (66.1, 73.2) < 0.0001
Cigarette Smoking < 0.01
Non-Smoker (Reference) 65.3 (63.0, 67.6)
Current Smoker −0.19 ± 0.12 62.3 (58.8, 65.9) 0.10
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Table 2 Simple linear regression for square root transformed 25(OH)D weighted for the household population aged
12 to 79 years, Canada, 2007 to 2009 (Continued)
Alcohol Use 0.01
Non-Drinker (Reference) 60.4 (56.7, 64.2)
Current Drinker 0.33 ± 0.10 65.6 (62.6, 68.7) 0.0006
Season 0.03
January to March (Reference) 58.6 (48.1, 70.0)
April to June 0.36 ± 0.41 64.2 (51.9, 77.8) 0.38
July to September 0.85 ± 0.42 72.2 (58.9, 87.0) 0.04
October to December 0.38 ± 0.39 64.6 (52.8, 77.5) 0.33
Latitude 0.02
43-44oN (Reference) 63.0 (59.3, 66.7)
45-47oN 0.43 ± 0.24## 70.0 (62.4, 78.1) 0.07
49-54oN −0.09 ± 0.12 61.5 (57.8, 65.3) 0.44
*For 91-day UV-B, the estimated mean increase in square root transformed 25(OH)D for a 1 kJ/m2 increase in solar UV-B irradiance between 11 am and 4 pm at
the CHMS collection sites averaged over the 91-days prior to blood draw; for other predictors, the estimated mean change in square root transformed 25(OH)D
compared to the reference category.
**For 91-day UV-B, the estimated mean increase in back transformed 25(OH)D (nmol/L) for a 1 kJ/m2 increase in solar UV-B irradiance between 11 am and 4 pm
at the CHMS collection sites averaged over the 91-days prior to blood draw; for other predictors,, the estimated mean change in back transformed 25(OH)D
(nmol/L) compared to the reference category.
*Significantly different than≥ 2 h/d (P = 0.004).
**Significantly different than > once/d (P<0.0001).
#Significantly different than≥ 30 kg/m2 (P<0.0001).
##Significantly different than 49–54oN (P = 0.01).
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91-day UV-B and 25(OH)D within the age group 60 to
79 years (P = 0.54).
Discussion
We used a secondary analysis of data from the 2007 to
2009 CHMS to examine the association between serum
concentrations of 25(OH)D and ground-level solar UV-
B. This is the first study in Canada to quantify the asso-
ciation between ambient solar UV-B and 25(OH)D in a
nationally representative sample. The comprehensive-
ness of the CHMS made it possible to adjust for per-
sonal and lifestyle factors that influence vitamin D status
and to examine effect modification. There is currently
no standardized method to assess sunlight exposure to
explain variation in vitamin D status. The time period
over which solar UV-B exposure is measured varies
markedly across studies, from one week up to one year.
In our study, 25(OH)D levels measured on a given date
were influenced the most by the cumulative effect of
ambient solar UV-B radiation over the 91-days prior to
blood draw. The most relevant time period for solar UV-
B exposure with respect to 25(OH)D has not been
addressed in previous studies. Unadjusted for other fac-
tors, season was a relatively good proxy for 91-day UV-B
compared to latitude. Significant differences in 25(OH)
D were evident only between the summer (July to
September) and winter (January to March) and between
high (49–54°N) and medium (45–47°N) latitudes.However, geographic heterogeneity across the CHMS
sites may be too small to capture the effect of latitude.
Additionally, it is difficult to separate season and latitude
effects due to the sampling design of the CHMS.
In a recent study from the Women’s Health Initiative
Calcium plus Vitamin D Clinical Trial, mean annual re-
gional solar irradiance at the location of residence
accounted for 1% of the total variability in 25(OH)D,
whereas month of blood draw accounted for 3% [37].
Compared to our results, this suggests that the one year
period over which solar irradiance was averaged was too
long to accurately capture the effect of solar UV-B ex-
posure. Another population-based study used data from
the Adventist Health Study-2 to examine erythemal zone
(average monthly noon erythemal radiation at the loca-
tion of residence) during the two months prior to blood
collection, UV season (categorized into three groups
according to erythemal zone), season, and latitude as
predictors of 25(OH)D [38]. In multivariable analysis,
UV season and erythemal zone were more strongly asso-
ciated with 25(OH)D than season and latitude, demon-
strating that measures of solar UV irradiance, as
opposed to season and latitude as proxies, are better
predictors of 25(OH)D. Our results demonstrate that fu-
ture epidemiologic studies should assess solar UV-B ex-
posure over a three month period to best capture the
variability in 25(OH)D concentrations.
Similar to our results, the population-based Canadian
Multicentre Osteoporosis Study identified fall and winter
Table 3 Multivariable linear regression for square root transformed 25(OH)D weighted for the household population
aged 12 to 79 years, Canada, 2007 to 2009
Variable β* ± SE Mean 25(OH)D** P Partial
(95% CI) r2***
91-Day UV-B 0.04 ± 0.01 0.5 (0.3, 0.8) 0.0001 0.03
Sex 0.01
Female (Reference) 54.2 (49.6, 58.9)
Male −0.31 ± 0.05 49.8 (48.3, 51.3) < 0.0001
Age 0.01
12-19 years −0.13 ± 0.10 52.3 (49.6, 55.0) 0.16
20-59 years (Reference) 54.2 (49.6, 58.9)
60-79 years 0.36 ± 0.09 59.6 (56.8, 62.4) 0.0001
Ethnicity 0.06
White (Reference) 54.2 (49.6, 58.9)
Non-White −1.10 ± 0.12 39.3 (36.5, 42.1) < 0.0001
Sun Exposure 0.01
< 30 min/d (Reference) 54.2 (49.6, 58.9)
≥ 30 min/d and< 2 h/d 0.22 ± 0.07* 57.5 (55.4, 59.6) 0.002
≥ 2 h/d 0.42 ± 0.09 60.5 (57.7, 63.4) < 0.0001
Vitamin D Supplementation 0.01
No (Reference) 54.2 (49.6, 58.9)
Yes 0.44 ± 0.06 60.8 (59.1, 62.6) < 0.0001
Milk Consumption 0.02
< Once/d (Reference) 54.2 (49.6, 58.9)
Once/d 0.29 ± 0.05** 58.6 (57.0, 60.2) < 0.0001
> Once/d 0.58 ± 0.06 63.1 (61.3, 64.9) < 0.0001
Body Mass Index 0.02
< 25 kg/m2 (Reference) 54.2 (49.6, 58.9)
≥ 25 and < 30 kg/m2 −0.13 ± 0.07# 52.2 (50.3, 54.2) 0.05
≥ 30 kg/m2 −0.63 ± 0.05 45.3 (44.0, 46.7) < 0.0001
Physical Activity Index 0.01
Inactive (Reference) 54.2 (49.6, 58.9)
Moderately Active 0.30 ± 0.08 57.1 (55.4, 58.8) 0.0009
Active 0.19 ± 0.06 58.6 (56.3, 61.1) 0.0002
Model r2 = 0.21.
*For 91-day UV-B, the estimated mean increase in square root transformed 25(OH)D for a 1 kJ/m2 increase in solar UV-B irradiance between 11 am and 4 pm at
the CHMS collection sites averaged over the 91-days prior to blood draw; for other predictors, the estimated mean change in square root transformed 25(OH)D
compared to the reference category.
**For 9-day UV-B, the estimated mean increase in back transformed 25(OH)D (nmol/L) for a 1 kJ/m2 increase in solar UV-B irradiance between 11 am and 4 pm at
the CHMS collection sites averaged over the 91-days prior to blood draw; for other predictors, the estimated mean change in back transformed 25(OH)D (nmol/L)
compared to the reference category.
***Total variance in square root transformed 25(OH)D explained by each predictor, controlling for all other variables.
*Significantly different than≥ 2 h/d (P = 0.003).
**Significantly different than > once/d (P<0.0001).
#Significantly different than≥ 30 kg/m2 (P<0.0001).
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lower vitamin D supplementation as the strongest pre-
dictors of decreased 25(OH)D among Canadians over
35 years of age across seven cities [25]. Age was not
found to be a significant independent predictor of 25(OH)D; however, most study participants were older
than 51 years of age. Regular participation in physical ac-
tivity was a significant predictor for females only. There
was a significant interaction between vitamin D supple-
mentation and season, which was not found in our
Table 4 Multivariable linear regression model for 91-day UV-B and square root transformed 25(OH)D within
subgroups of age and physical activity index, weighted for the household population aged 12 to 79 years, Canada,
2007 to 2009
Effect Modifier β* ± SE Mean 25(OH)D** P Model Partial
(95% CI) r2 r2***
Age
12-19 years 0.07 ± 0.01 0.9 (0.6, 1.3) < 0.0001 0.27 0.07
20-59 years 0.04 ± 0.01 0.6 (0.3, 0.9) 0.0001 0.22 0.03
60-79 years −0.01 ± 0.01 −0.1 (−0.5, 0.2) 0.54 0.09 <0.01
Physical Activity Index
Inactive 0.03 ± 0.01 0.5 (0.0, 0.8) 0.0009 0.20 0.02
Moderately Active 0.03 ± 0.01 0.4 (0.1, 0.8) 0.02 0.19 0.01
Active 0.06 ± 0.02 0.9 (0.4, 1.3) 0.0001 0.19 0.07
Adjusted for sex, age, ethnicity, sun exposure, vitamin D supplementation, milk consumption, BMI, and PAI.
*Estimated mean increase in square root transformed 25(OH)D for a 1 kJ/m2 increase in solar UV-B irradiance between 11 am and 4 pm at the CHMS collection
sites averaged over the 91-days prior to blood draw (91-day UV-B).
**Estimated mean change in back transformed 25(OH)D (nmol/L) for a 1 kJ/m2 increase in solar UV-B irradiance between 11 am and 4 pm for the CHMS collection
sites averaged over the 91-days prior to blood draw (91-day UV-B).
***Total variance in square root transformed 25(OH)D explained by 91-day UV-B, controlling for all other variables.
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for respondents to the CHMS was not measured. In our
study, we found that age and PAI were significant effect
modifiers of the relationship between 91-day UV-B and
25(OH)D. The interaction with age may reflect that syn-
thesis of vitamin D3 decreases with increasing age due
to reduced concentrations of 7-dehydrocholesterol in
the skin as well as alterations in skin morphology [14].
Although the association between 91-day UV-B and 25
(OH)D was strongest within the youngest age group, the
oldest age group had the highest levels of 25(OH)D. This
may suggest that dietary and supplemental intake of
vitamin D play an important role in achieving adequate
levels of 25(OH)D among older individuals. The inter-
action with PAI may suggest that physical activity is a
good proxy for time spent outdoors in the sun. This is
consistent with results from the Third National Health
and Nutrition Examination Survey, in which regular out-
door physical activity, as opposed to intense indoor
physical activity, was associated with higher levels of 25
(OH)D [39].
We estimate that a 10 to 15% decrease in solar ery-
themal UV projected over the current century [2,3] cor-
responding to a decrease in solar UV-B irradiance of less
than 2 kJ/m2 in Canada, would be associated with less
than a 1 nmol/L decrease in mean 25(OH)D for the
population. Although solar UV-B irradiance is signifi-
cantly associated with 25(OH)D concentrations, the
small magnitude of effect may be due to inadequate sun
exposure at the individual level as a result of behaviour
and/or the “vitamin D winter” that is characteristic of
high latitudes. Public health messages should increase
awareness about practising safe sun exposure optimal
for vitamin D3 synthesis during the summer in additionto promoting dietary and supplemental intake of vitamin
D and proper nutrition and physical activity to maintain
a healthy body weight. Vitamin D reference intakes
should be set at levels high enough to prevent vitamin D
insufficiency among individuals who do not obtain ad-
equate solar UV-B exposure.
The main strengths of our study include its large sam-
ple size, which was representative of the Canadian popu-
lation, and the low frequency of missing data. In
contrast to most epidemiologic studies, we did not use
season or latitude as a proxy for solar UV-B exposure,
and we were able to examine personal and lifestyle fac-
tors that influence vitamin D status. A limitation of our
study is the low response rate for blood draw among the
CHMS respondents. Measurement error associated with
solar UV-B irradiance, serum 25(OH)D concentrations,
and other predictors likely contribute to the low variabil-
ity in 25(OH)D captured in the multivariable regression
model. Solar UV-B irradiances were calculated for clear-
sky conditions because of the highly variable and unpre-
dictable effect of clouds on solar UV-B irradiance [9].
The ECMWF cloud field does not contain cloud base
and cloud top heights, which are required in the TUV
model. The adjustment for background aerosols did not
account for highly polluted regions, which may reduce
ground-level solar UV-B due to scattering and absorp-
tion [9]. Lastly, solar UV-B irradiances calculated using
the TUV model were not weighted for the vitamin D ac-
tion spectrum, which corresponds to the conversion of
7-dehydrocholesterol to pre-vitamin D3. Limitations of
the CHMS data include a lack of assessment of percent
fat, skin pigmentation, the duration or timing of recent
sun exposure, sunscreen use in all participants, typical
clothing coverage outdoors, recent travel to a sunny
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mentation. Despite these limitations, our results are
comparable to recent predictive models that explained
21 to 42% of the total variability in 25(OH)D [37,38,40-
42]. Additional factors not accounted for, such as genetic
differences in vitamin D related genes, may play an im-
portant role in determining 25(OH)D concentrations
[43,44]. It is likely that many factors each impart a small
but significant influence on the vitamin D status of
human populations.
Conclusions
Solar UV-B irradiance explains a small but statistically sig-
nificant proportion of the total variability in 25(OH)D
concentrations. Future climate change and ozone recovery
is expected to have a small effect on mean serum 25(OH)D
for the Canadian population, at latitudes 43–54°N, sug-
gesting that public health messages and interventions to
promote sufficient vitamin D status should target behav-
ioural factors including safe sun exposure with sunscreen
use, enhanced dietary and supplemental intake of vitamin
D and maintenance of a healthy body weight. These
results likely pertain to other populations in developed
countries at similar latitudes. Future investigations using
longitudinal studies and observations of UV-B irradiance
are needed to better evaluate the causal relationship be-
tween ambient solar UV-B and vitamin D status in
humans.
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